Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Case Reports in Women'S Health
|
June 12, 2026
Diagnosing placenta accreta spectrum
Helena C Bartels, Eric Jauniaux
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|
August 11, 2021
Authors' response to letter to the editor: Quality of life after placenta accreta spectrum: Should women be informed of mortality risk?
Helena C Bartels, Donal J Brennan
Case Reports in Women'S Health
|
July 18, 2024
Complex caesarean delivery
Helena C Bartels, Donal J Brennan
Case Reports in Women'S Health
|
November 13, 2023
Placenta accreta spectrum - the ongoing evolution of an iatrogenic condition
Helena C Bartels, Donal J Brennan
Clinical Obstetrics and Gynecology
|
June 16, 2026
Reconsidering the Role of Attempted Uterine Conservation by Intentional Placental Retention in Placenta Accreta Spectrum
Helena C Bartels, Sebastian R Hobson
Clinical Obstetrics and Gynecology
|
October 7, 2025
The Role of Angiogenic Factors in Fetal Growth Restriction
Helena C Bartels, Sebastian R Hobson
Plos Medicine
|
June 12, 2026
Placenta accreta spectrum in the 21st century: Challenging dogma and redefining disorder
Eric Jauniaux, Helena C Bartels, Yalda Afshar
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
July 24, 2024
Looking back to look forward: Has the time arrived for active management of obstetricians in placenta accreta spectrum?
Helena C Bartels, Paul Downey, Donal J Brennan
Annals of Surgical Oncology
|
October 30, 2025
ASO Visual Abstract: Efficacy of Poly(ADP-ribose) Polymerase Inhibitors according to Clinical Risk in Newly Diagnosed, Advanced Ovarian Cancer-A Meta-analysis of Phase III Clinical Trials
Gillian Reid-Schachter, Helena C Bartels, Donal J Brennan
Annals of Surgical Oncology
|
October 3, 2025
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors According to Clinical Risk in Newly Diagnosed, Advanced Ovarian Cancer: A Meta-analysis of Phase III Clinical Trials
Gillian Reid-Schachter, Helena C Bartels, Donal J Brennan
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Case Reports in Women'S Health
|
June 12, 2026
Diagnosing placenta accreta spectrum
Helena C Bartels, Eric Jauniaux
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|
August 11, 2021
Authors' response to letter to the editor: Quality of life after placenta accreta spectrum: Should women be informed of mortality risk?
Helena C Bartels, Donal J Brennan
Case Reports in Women'S Health
|
July 18, 2024
Complex caesarean delivery
Helena C Bartels, Donal J Brennan
Case Reports in Women'S Health
|
November 13, 2023
Placenta accreta spectrum - the ongoing evolution of an iatrogenic condition
Helena C Bartels, Donal J Brennan
Clinical Obstetrics and Gynecology
|
June 16, 2026
Reconsidering the Role of Attempted Uterine Conservation by Intentional Placental Retention in Placenta Accreta Spectrum
Helena C Bartels, Sebastian R Hobson
Clinical Obstetrics and Gynecology
|
October 7, 2025
The Role of Angiogenic Factors in Fetal Growth Restriction
Helena C Bartels, Sebastian R Hobson
Plos Medicine
|
June 12, 2026
Placenta accreta spectrum in the 21st century: Challenging dogma and redefining disorder
Eric Jauniaux, Helena C Bartels, Yalda Afshar
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
July 24, 2024
Looking back to look forward: Has the time arrived for active management of obstetricians in placenta accreta spectrum?
Helena C Bartels, Paul Downey, Donal J Brennan
Annals of Surgical Oncology
|
October 30, 2025
ASO Visual Abstract: Efficacy of Poly(ADP-ribose) Polymerase Inhibitors according to Clinical Risk in Newly Diagnosed, Advanced Ovarian Cancer-A Meta-analysis of Phase III Clinical Trials
Gillian Reid-Schachter, Helena C Bartels, Donal J Brennan
Annals of Surgical Oncology
|
October 3, 2025
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors According to Clinical Risk in Newly Diagnosed, Advanced Ovarian Cancer: A Meta-analysis of Phase III Clinical Trials
Gillian Reid-Schachter, Helena C Bartels, Donal J Brennan
Page
of 6